We serve Chemical Name:8-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one CAS:116815-03-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![8-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one](https://a.dearchem.com/CAS2/116815-03-3.png)
Chemical Name:8-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one
CAS.NO:116815-03-3
Synonyms:8-chloro-1,2,3,4-tetrahydro-1-benzazepin-5-one
Molecular Formula:C10H10ClNO
Molecular Weight:195.64500
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:352.6ºC at 760mmHg
Density:1.234g/cm3
Index of Refraction:1.562
PSA:29.10000
Exact Mass:195.04500
LogP:2.86640
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 8-chloro-1,2,3,4-tetrahydro-1-benzazepin-5-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-chloro-1,2,3,4-tetrahydro-1-benzazepin-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-chloro-1,2,3,4-tetrahydro-1-benzazepin-5-one Use and application,8-chloro-1,2,3,4-tetrahydro-1-benzazepin-5-one technical grade,usp/ep/jp grade.
Related News: Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. N-((2S,3R,5R)-6-(((S)-1-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-5-benzyl-3-hydroxy-6-oxo-1-phenylhexan-2-yl)-4-benzoylbenzamide manufacturers A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. (RS)-6-acetoxy-4-isopropyl-6-(2-oxopropyl)cyclohexa-2,4-dien-1-one suppliers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. 1-((3-methylbut-3-en-2-ylidene)amino)pyrrolidine-2,5-dione vendor & factory Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine.,Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine.
